Symbols / GLPG Stock $28.60 -0.28% Galapagos NV

Healthcare • Biotechnology • Belgium • NMS
GLPG (Stock) Chart
O: — H: — L: — C: — V: —
SMA 20: — SMA 50: — SMA 200: —
Stock Fundamentals
Scroll to Statements
Index EQUITY
Sector Healthcare
Industry Biotechnology
CEO Mr. Henry Gosebruch
Exch · Country NMS · Belgium
Market Cap 1.92B
Enterprise Value -1.11B
Income 319.49M
Sales 1.11B
FCF (ttm) 344.64M
Book/sh 2.90
Cash/sh 45.50
Employees —
Insider 10d —
IPO Feb 27, 2012
Div forward ($/yr)
Div TTM ($/yr)
Dividend Yield
Ex-Div Date
5Y Avg Yield
Yield vs 5Y Avg
Payout 0.00%
P/E 5.04
Forward P/E -17.88
PEG —
P/S 1.73
P/B 9.87
P/C —
EV/EBITDA -1.95
EV/Sales -0.99
Quick Ratio 19.96
Current Ratio 20.14
Debt/Eq 0.21
LT Debt/Eq —
EPS (ttm) 5.68
EPS next Y -1.60
EPS Growth 30.36%
Revenue Growth 10.93%
EPS Gr Q/Q 29.91%
Rev Gr Q/Q —
Earnings (next) 2026-05-06
Earnings (prior) 2026-03-26
ROA 8.87%
ROE 10.42%
ROIC —
Gross Margin 56.02%
Oper. Margin 88.00%
Profit Margin 28.85%
Shs Outstand 65.90M
Shs Float 44.54M
Insider Own 25.35%
Instit Own 22.61%
Short Float 3.39%
Short Ratio 6.95
Short Interest 1.37M
52W High 37.78
vs 52W High -24.30%
52W Low 24.74
vs 52W Low 15.60%
Beta 0.15
Impl. Vol. —
Rel Volume 0.73
Avg Volume 140.57K
Volume 102.33K
Target (mean) $28.45
Tgt Median $28.45
Tgt Low $28.45
Tgt High $28.45
# Analysts 1
Recom None
Prev Close $28.68
Price $28.60
Change -0.28%
About

Galapagos NV, a biotechnology company, develops medicines focusing on oncology and immunology primarily in the United States and Europe. The company's pipeline products comprise GLPG3667 that is in phase 2 clinical trial in dermatomyositis and systemic lupus erythematosus; GLPG5101, a CD19 CAR-T product candidate manufactured at point-of-care, currently in Phase1/2 trial in relapsed/refractory non-hodgkin lymphoma; and GLPG5301, a BCMA CAR-T product candidate manufactured at point-of-care, currently in phase 1/2 in relapsed/refractory multiple myeloma. The company has collaboration agreements with Gilead Sciences, Inc. The company was incorporated in 1999 and is headquartered in Mechelen, Belgium.

Valuation Models

Price estimates from analyst targets and simple models.

1. Analyst consensus
$28.45
Mean price target
2. Current target
$28.60
Latest analyst target
3. DCF / Fair value
$94.14
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$28.60
Low
$28.45
High
$28.45
Mean
$28.45

Latest analyst rating changes

Date Action Analyst Rating Change Price Target
2026-02-25 main RBC Capital Sector Perform → Sector Perform $33
2025-11-07 main RBC Capital Sector Perform → Sector Perform $32
2025-10-22 main RBC Capital Sector Perform → Sector Perform $28
2025-10-21 up Leerink Partners Market Perform → Outperform $40
2025-02-14 down Morgan Stanley Equal-Weight → Underweight $22
2025-01-23 down Barclays Equal-Weight → Underweight —
2024-11-01 main RBC Capital Sector Perform → Sector Perform $30
2024-09-09 init Leerink Partners — → Market Perform $24
2024-04-22 main Morgan Stanley Equal-Weight → Equal-Weight $38
2024-04-01 down B of A Securities Neutral → Underperform $31
2024-03-28 down B of A Securities Neutral → Underperform $31
2024-01-02 main B of A Securities Neutral → Neutral $44
2023-08-07 main Morgan Stanley Equal-Weight → Equal-Weight $40
2023-08-01 reit Morgan Stanley Equal-Weight → Equal-Weight $42
2023-07-31 reit Morgan Stanley Equal-Weight → Equal-Weight $42
2023-07-24 reit Morgan Stanley Equal-Weight → Equal-Weight $42
2023-07-17 reit Morgan Stanley Equal-Weight → Equal-Weight $42
2023-06-26 reit Morgan Stanley Equal-Weight → Equal-Weight $42
2023-06-20 reit Morgan Stanley — → Equal-Weight $42
2023-06-12 reit Morgan Stanley Equal-Weight → Equal-Weight $42
News
RSS: Latest GLPG news
Insider Transactions

No recent insider transactions.

Financials
Statement View
Amounts in millions (2 decimals, no suffix) • EPS per share (2 decimals) • Trend = period evolution • YoY Growth = previous period %
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Revenue
1,112.25
+303.50%
275.65
+14.99%
239.72
-0.63%
241.25
Operating Revenue
1,112.25
+303.50%
275.65
+14.99%
239.72
-0.63%
241.25
Cost Of Revenue
29.74
-14.71%
34.86
0.00
0.00
Reconciled Cost Of Revenue
29.74
+1072.56%
2.54
0.00
0.00
Gross Profit
1,082.51
+349.57%
240.79
+0.44%
239.72
-0.63%
241.25
Operating Expense
581.12
+35.42%
429.12
+30.84%
327.99
-11.90%
372.31
Research And Development
459.42
+36.95%
335.46
+39.03%
241.29
-10.56%
269.80
Selling General And Administration
111.96
+15.57%
96.88
+2.79%
94.25
-8.77%
103.31
Selling And Marketing Expense
1.39
-50.52%
2.81
+58.39%
1.78
+40.17%
1.27
General And Administrative Expense
110.57
+17.54%
94.07
+1.72%
92.48
-9.38%
102.04
Salaries And Wages
80.99
+36.80%
59.20
-14.32%
69.09
-11.68%
78.23
Other Gand A
29.58
-15.16%
34.86
+49.11%
23.38
-1.82%
23.81
Other Operating Expenses
0.25
+101.55%
-16.39
+30.71%
-23.65
-151.89%
-9.39
Total Expenses
610.86
+31.65%
463.99
+41.47%
327.99
-11.90%
372.31
Operating Income
501.39
+366.22%
-188.34
-113.38%
-88.26
+32.65%
-131.06
Total Operating Income As Reported
295.04
+256.65%
-188.34
-113.38%
-88.26
+32.65%
-131.06
EBITDA
358.96
+728.54%
43.33
-15.11%
51.04
+1218.10%
3.87
Normalized EBITDA
604.67
+1252.41%
-52.47
-250.84%
34.78
+173.04%
-47.63
Reconciled Depreciation
55.88
+22.80%
45.50
+4.26%
43.64
-33.44%
65.57
EBIT
303.09
+14041.49%
-2.17
-129.40%
7.39
+111.99%
-61.69
Total Unusual Items
-245.71
-356.49%
95.80
+489.44%
16.25
-68.44%
51.50
Total Unusual Items Excluding Goodwill
-245.71
-356.49%
95.80
+489.44%
16.25
-68.44%
51.50
Special Income Charges
-206.35
—
—
—
Impairment Of Capital Assets
228.11
—
—
—
Restructuring And Mergern Acquisition
-21.76
—
—
—
Net Income
320.88
+333.15%
74.08
-65.01%
211.70
+197.11%
-217.99
Pretax Income
300.87
+9852.71%
-3.08
-154.84%
5.62
+107.94%
-70.85
Net Non Operating Interest Income Expense
45.19
-49.49%
89.46
+15.23%
77.64
+791.45%
8.71
Interest Expense Non Operating
2.22
+143.36%
0.91
-48.53%
1.77
-80.67%
9.15
Net Interest Income
45.19
-49.49%
89.46
+15.23%
77.64
+791.45%
8.71
Interest Expense
2.22
+143.36%
0.91
-48.53%
1.77
-80.67%
9.15
Interest Income Non Operating
46.34
-48.38%
89.77
+12.77%
79.61
+339.97%
18.09
Interest Income
46.34
-48.38%
89.77
+12.77%
79.61
+339.97%
18.09
Other Income Expense
-245.71
-356.49%
95.80
+489.44%
16.25
-68.44%
51.50
Gain On Sale Of Security
-39.36
-141.08%
95.80
+489.44%
16.25
-68.44%
51.50
Tax Provision
-18.62
-932.78%
-1.80
-118.76%
9.61
+1580.59%
0.57
Tax Rate For Calcs
0.00
+0.00%
0.00
+0.00%
0.00
+0.00%
0.00
Tax Effect Of Unusual Items
-51.60
-356.49%
20.12
+489.44%
3.41
-68.44%
10.81
Net Income Including Noncontrolling Interests
320.88
+333.15%
74.08
-65.01%
211.70
+197.11%
-217.99
Net Income From Continuing Operation Net Minority Interest
319.49
+25021.37%
-1.28
+67.85%
-3.99
+94.42%
-71.42
Net Income From Continuing And Discontinued Operation
320.88
+333.15%
74.08
-65.01%
211.70
+197.11%
-217.99
Net Income Continuous Operations
319.49
+25021.37%
-1.28
+67.85%
-3.99
+94.42%
-71.42
Net Income Discontinuous Operations
1.39
-98.15%
75.36
-65.06%
215.69
+247.15%
-146.57
Normalized Income
513.60
+767.36%
-76.96
-357.36%
-16.83
+84.99%
-112.11
Net Income Common Stockholders
320.88
+333.15%
74.08
-65.01%
211.70
+197.11%
-217.99
Diluted EPS
4.87
+334.82%
1.12
-65.11%
3.21
+196.69%
-3.32
Basic EPS
4.87
+334.82%
1.12
-65.11%
3.21
+196.69%
-3.32
Basic Average Shares
65.90
-0.37%
66.14
+0.40%
65.88
+0.34%
65.66
Diluted Average Shares
65.90
-0.37%
66.14
+0.40%
65.88
+0.34%
65.66
Diluted NI Availto Com Stockholders
320.88
+333.15%
74.08
-65.01%
211.70
+197.11%
-217.99
Depreciation Amortization Depletion Income Statement
9.49
-27.98%
13.17
-18.14%
16.09
+87.37%
8.59
Depreciation And Amortization In Income Statement
9.49
-27.98%
13.17
-18.14%
16.09
+87.37%
8.59
Depreciation Income Statement
9.49
-27.98%
13.17
-18.14%
16.09
+87.37%
8.59
Total Other Finance Cost
-1.07
-78.86%
-0.60
-395.05%
0.20
-12.17%
0.23
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Total Assets
3,406.52
-17.63%
4,135.72
-5.09%
4,357.40
-7.96%
4,734.35
Current Assets
3,079.46
-7.79%
3,339.45
-13.52%
3,861.59
-8.86%
4,236.85
Cash Cash Equivalents And Short Term Investments
2,998.05
-3.83%
3,117.57
-15.39%
3,684.50
-10.00%
4,094.06
Cash And Cash Equivalents
87.87
+36.78%
64.24
-61.49%
166.80
-67.17%
508.12
Cash Equivalents
—
0.00
-100.00%
95.00
+90.00%
50.00
Cash Financial
87.87
+36.78%
64.24
-10.53%
71.80
-84.33%
458.12
Other Short Term Investments
2,910.18
-4.69%
3,053.33
-13.20%
3,517.70
-1.90%
3,585.95
Receivables
53.20
-39.60%
88.09
+34.17%
65.66
-15.11%
77.34
Accounts Receivable
9.57
-70.53%
32.47
+85.61%
17.49
-37.95%
28.19
Other Receivables
43.63
-21.55%
55.62
+15.49%
48.16
-2.01%
49.15
Inventory
22.49
-56.06%
51.19
-30.80%
73.98
+39.78%
52.92
Raw Materials
22.49
-56.06%
51.19
-7.37%
55.26
+41.44%
39.07
Work In Process
—
0.00
-100.00%
12.60
+117.54%
5.79
Finished Goods
—
0.00
-100.00%
6.12
-24.13%
8.06
Prepaid Assets
0.10
+0.00%
0.10
-86.04%
0.74
+51.23%
0.49
Current Deferred Assets
5.61
-81.43%
30.21
+106.49%
14.63
+21.64%
12.03
Restricted Cash
0.00
-100.00%
41.16
0.00
—
Assets Held For Sale Current
0.00
-100.00%
11.12
-49.67%
22.09
0.00
Other Current Assets
—
—
—
0.00
Total Non Current Assets
327.06
-58.93%
796.27
+60.60%
495.81
-0.34%
497.50
Net PPE
80.66
-34.37%
122.90
-2.71%
126.32
-18.11%
154.25
Gross PPE
140.28
-20.27%
175.95
-0.92%
177.58
-17.54%
215.36
Accumulated Depreciation
-59.62
-12.38%
-53.05
-3.49%
-51.26
+16.12%
-61.11
Properties
0.00
0.00
0.00
0.00
Land And Improvements
84.99
-1.19%
86.01
-5.17%
90.70
+2.24%
88.72
Machinery Furniture Equipment
37.92
-33.18%
56.75
+15.73%
49.03
-27.13%
67.28
Other Properties
3.18
-63.04%
8.61
-41.35%
14.67
-40.18%
24.53
Leases
14.19
-42.27%
24.59
+6.09%
23.17
-33.47%
34.83
Goodwill And Other Intangible Assets
0.85
-99.64%
234.87
+18.94%
197.46
-8.65%
216.17
Goodwill
0.00
-100.00%
70.01
+0.65%
69.56
-0.37%
69.81
Other Intangible Assets
0.85
-99.49%
164.86
+28.89%
127.91
-12.60%
146.35
Investments And Advances
46.81
-81.51%
253.12
+1764.63%
13.57
0.00
Long Term Equity Investment
46.81
-11.58%
52.94
+289.99%
13.57
—
Non Current Accounts Receivable
174.41
-0.45%
175.19
+24.03%
141.25
+17.77%
119.94
Non Current Deferred Assets
0.20
-86.77%
1.47
+30.91%
1.13
-17.39%
1.36
Non Current Deferred Taxes Assets
0.20
-86.77%
1.47
+30.91%
1.13
-17.39%
1.36
Non Current Prepaid Assets
0.00
-100.00%
5.46
-46.60%
10.22
0.00
Other Non Current Assets
2.96
-8.95%
3.25
-44.44%
5.85
+1.26%
5.78
Total Liabilities Net Minority Interest
170.65
-86.22%
1,238.78
-20.68%
1,561.83
-29.28%
2,208.32
Current Liabilities
152.86
-54.38%
335.08
-21.75%
428.22
-18.05%
522.54
Payables And Accrued Expenses
33.60
-48.76%
65.57
-51.52%
135.26
-4.20%
141.19
Payables
33.58
-47.93%
64.48
-52.13%
134.71
-4.15%
140.54
Accounts Payable
32.62
-49.21%
64.23
-52.30%
134.65
+1.02%
133.30
Other Payable
—
—
—
6.22
Current Accrued Expenses
0.02
-98.17%
1.09
+99.27%
0.55
-15.82%
0.65
Employee Benefits
0.00
-100.00%
2.10
-8.46%
2.29
-58.61%
5.54
Pensionand Other Post Retirement Benefit Plans Current
33.11
0.00
—
—
Total Tax Payable
0.96
+283.94%
0.25
+344.64%
0.06
-94.52%
1.02
Current Debt And Capital Lease Obligation
1.73
-50.30%
3.48
-25.21%
4.65
-35.47%
7.21
Current Capital Lease Obligation
1.73
-50.30%
3.48
-25.21%
4.65
-35.47%
7.21
Current Deferred Liabilities
0.03
-99.99%
232.48
-9.28%
256.27
-29.91%
365.63
Current Deferred Revenue
0.03
-99.99%
232.48
-9.28%
256.27
-29.91%
365.63
Other Current Liabilities
38.90
+15.93%
33.55
+4.72%
32.04
+276.77%
8.51
Total Non Current Liabilities Net Minority Interest
17.79
-98.03%
903.70
-20.28%
1,133.61
-32.76%
1,685.79
Long Term Debt And Capital Lease Obligation
5.19
-37.09%
8.24
+66.73%
4.94
-66.35%
14.69
Long Term Capital Lease Obligation
5.19
-37.09%
8.24
+66.73%
4.94
-66.35%
14.69
Non Current Pension And Other Postretirement Benefit Plans
0.00
-100.00%
2.10
-8.46%
2.29
-58.61%
5.54
Non Current Deferred Liabilities
0.00
-100.00%
859.54
-21.49%
1,094.80
-33.40%
1,643.75
Non Current Deferred Revenue
0.00
-100.00%
838.88
-21.69%
1,071.19
-34.02%
1,623.60
Non Current Deferred Taxes Liabilities
0.00
-100.00%
20.66
-12.48%
23.61
+17.17%
20.15
Other Non Current Liabilities
12.60
-62.74%
33.82
+7.13%
31.57
+44.76%
21.81
Stockholders Equity
3,235.87
+11.70%
2,896.94
+3.63%
2,795.57
+10.67%
2,526.03
Common Stock Equity
3,235.87
+11.70%
2,896.94
+3.63%
2,795.57
+10.67%
2,526.03
Capital Stock
293.94
+0.00%
293.94
+0.00%
293.94
+0.11%
293.60
Common Stock
293.94
+0.00%
293.94
+0.00%
293.94
+0.11%
293.60
Share Issued
65.90
+0.00%
65.90
+0.00%
65.90
+0.09%
65.84
Ordinary Shares Number
65.90
+0.00%
65.90
+0.00%
65.90
+0.09%
65.84
Additional Paid In Capital
2,736.99
+0.00%
2,736.99
+0.00%
2,736.99
+0.05%
2,735.56
Retained Earnings
210.58
+256.79%
-134.31
+41.16%
-228.27
+54.04%
-496.69
Gains Losses Not Affecting Retained Earnings
-5.64
-1896.18%
0.31
+104.43%
-7.09
-10.01%
-6.45
Other Equity Adjustments
-8.64
-173.50%
-3.16
+46.38%
-5.89
-21.37%
-4.85
Total Equity Gross Minority Interest
3,235.87
+11.70%
2,896.94
+3.63%
2,795.57
+10.67%
2,526.03
Total Capitalization
3,235.87
+11.70%
2,896.94
+3.63%
2,795.57
+10.67%
2,526.03
Working Capital
2,926.59
-2.59%
3,004.37
-12.49%
3,433.37
-7.56%
3,714.31
Invested Capital
3,235.87
+11.70%
2,896.94
+3.63%
2,795.57
+10.67%
2,526.03
Total Debt
6.92
-41.01%
11.72
+22.16%
9.60
-56.18%
21.90
Capital Lease Obligations
6.92
-41.01%
11.72
+22.16%
9.60
-56.18%
21.90
Net Tangible Assets
3,235.02
+21.52%
2,662.07
+2.46%
2,598.10
+12.48%
2,309.86
Tangible Book Value
3,235.02
+21.52%
2,662.07
+2.46%
2,598.10
+12.48%
2,309.86
Current Provisions
45.50
—
—
—
Financial Assets Designatedas Fair Value Through Profitor Loss Total
—
—
13.57
0.00
Foreign Currency Translation Adjustments
3.00
-13.68%
3.47
+389.09%
-1.20
+24.61%
-1.59
Investmentin Financial Assets
0.00
-100.00%
200.18
0.00
0.00
Non Current Note Receivables
21.18
0.00
—
—
Line Item Trend 2025-12-31 2024-12-31 2023-12-31 2022-12-31
Operating Cash Flow
-257.46
+19.55%
-320.03
+21.17%
-405.97
+18.89%
-500.54
Cash Flow From Continuing Operating Activities
-257.46
+19.55%
-320.03
+21.17%
-405.97
+18.89%
-500.54
Net Income From Continuing Operations
320.88
+333.15%
74.08
-65.01%
211.70
+197.11%
-217.99
Depreciation Amortization Depletion
55.88
+22.80%
45.50
+4.26%
43.64
-33.44%
65.57
Depreciation
55.88
+22.80%
45.50
+4.26%
43.64
-33.44%
65.57
Depreciation And Amortization
55.88
+22.80%
45.50
+4.26%
43.64
-33.44%
65.57
Other Non Cash Items
-100.84
+14.39%
-117.79
-28.43%
-91.72
-9013.41%
1.03
Pension And Employee Benefit Expense
-2.35
-348.85%
-0.52
-4863.64%
0.01
-91.91%
0.14
Stock Based Compensation
24.00
+20.68%
19.89
-64.94%
56.72
-35.92%
88.51
Asset Impairment Charge
218.47
+2165.57%
9.64
0.00
0.00
Deferred Tax
-18.14
-963.81%
-1.71
-114.59%
11.69
+311.01%
2.84
Deferred Income Tax
-18.14
-963.81%
-1.71
-114.59%
11.69
+311.01%
2.84
Operating Gains Losses
17.68
+123.16%
-76.34
-505.84%
18.81
+144.74%
-42.04
Gain Loss On Investment Securities
-22.75
-568525.00%
-0.00
+77.78%
-0.02
+90.32%
-0.19
Unrealized Gain Loss On Investment Securities
50.74
+201.50%
-49.98
-124.14%
-22.30
-221.84%
-6.93
Net Foreign Currency Exchange Gain Loss
43.84
+283.74%
-23.86
-219.84%
19.91
+147.43%
-41.97
Gain Loss On Sale Of PPE
0.03
+237.50%
0.01
+100.73%
-1.09
-4643.48%
-0.02
Change In Working Capital
-876.57
-173.46%
-320.55
+53.71%
-692.43
-82.47%
-379.47
Change In Receivables
86.59
+378.82%
-31.05
+20.60%
-39.11
-156.70%
68.98
Change In Inventory
28.85
+25.23%
23.04
+195.69%
-24.08
+30.39%
-34.59
Change In Other Working Capital
-1,025.82
-301.48%
-255.51
+61.35%
-661.06
-72.32%
-383.62
Change In Other Current Liabilities
33.81
+159.29%
-57.03
-279.23%
31.82
+205.19%
-30.25
Investing Cash Flow
288.81
+30.92%
220.60
+209.89%
71.19
+105.72%
-1,245.51
Cash Flow From Continuing Investing Activities
288.81
+30.92%
220.60
+209.89%
71.19
+105.72%
-1,245.51
Net PPE Purchase And Sale
-13.24
+20.79%
-16.72
-2.68%
-16.28
+38.91%
-26.65
Purchase Of PPE
-13.70
+18.04%
-16.72
+10.62%
-18.71
+31.70%
-27.39
Sale Of PPE
0.46
+15300.00%
0.00
-99.88%
2.43
+228.28%
0.74
Capital Expenditure
-13.86
+83.12%
-82.11
-326.04%
-19.27
+47.84%
-36.95
Net Investment Purchase And Sale
242.33
-14.11%
282.15
+251.52%
80.27
+107.38%
-1,087.03
Purchase Of Investment
-3,465.06
-2.33%
-3,386.29
+0.52%
-3,404.14
-24.76%
-2,728.63
Sale Of Investment
3,707.39
+1.06%
3,668.44
+5.28%
3,484.41
+112.26%
1,641.60
Net Business Purchase And Sale
19.43
+317.13%
-8.95
-27.84%
-7.00
+93.93%
-115.27
Purchase Of Business
0.00
+100.00%
-8.95
-27.84%
-7.00
+93.93%
-115.27
Gain Loss On Sale Of Business
-1.08
+97.91%
-51.96
0.00
0.00
Net Intangibles Purchase And Sale
-0.15
+99.76%
-65.39
-11432.63%
-0.57
+94.07%
-9.56
Purchase Of Intangibles
-0.15
+99.76%
-65.39
-11432.63%
-0.57
+94.07%
-9.56
Net Other Investing Changes
-20.00
—
—
-10.00
Financing Cash Flow
-3.27
+33.53%
-4.92
+1.54%
-5.00
-236.31%
-1.49
Cash Flow From Continuing Financing Activities
-3.27
+33.53%
-4.92
+1.54%
-5.00
-236.31%
-1.49
Net Issuance Payments Of Debt
-3.27
+33.53%
-4.92
+27.28%
-6.77
+17.25%
-8.18
Repayment Of Debt
-3.27
+33.53%
-4.92
+27.28%
-6.77
+17.25%
-8.18
Long Term Debt Payments
-3.27
+33.53%
-4.92
+27.28%
-6.77
+17.25%
-8.18
Net Long Term Debt Issuance
-3.27
+33.53%
-4.92
+27.28%
-6.77
+17.25%
-8.18
Net Common Stock Issuance
—
—
—
—
Proceeds From Stock Option Exercised
—
—
—
—
Net Other Financing Charges
—
—
1.77
-73.56%
6.70
Changes In Cash
28.09
+126.91%
-104.35
+69.29%
-339.79
+80.56%
-1,747.54
Effect Of Exchange Rate Changes
-4.46
-350.06%
1.78
+217.08%
-1.52
-106.83%
22.29
Beginning Cash Position
64.24
-61.49%
166.81
-67.17%
508.12
-77.25%
2,233.37
End Cash Position
87.87
+36.78%
64.24
-61.49%
166.81
-67.17%
508.12
Free Cash Flow
-271.31
+32.53%
-402.14
+5.43%
-425.24
+20.88%
-537.49
Common Stock Issuance
—
—
—
—
Interest Paid CFO
-0.46
+32.66%
-0.69
+81.91%
-3.81
+69.44%
-12.46
Interest Received CFI
60.45
+104.92%
29.50
+99.78%
14.77
+392.82%
3.00
Interest Received CFO
51.28
-47.41%
97.52
+39.50%
69.91
+1344.66%
4.84
Issuance Of Capital Stock
—
—
—
—
Other Cash Adjustment Outside Changein Cash
—
—
—
—
Sale Of Business
19.43
—
0.00
0.00
Taxes Refund Paid
-0.37
-191.63%
0.41
+104.97%
-8.17
-84.30%
-4.43
SEC Filings

No SEC filings found for this symbol (may be non-US or ticker not in SEC index).

Trades
Date User Broker Pattern Type Position Size Entry Price Trade P&L Status
Posts
Published Title Author Category